References
- Frischer M., Leyland A., Cormack R., Goldberg D., Bloor M., Green S., Taylor A., Covell R., McKeganey N., Piatt S. Estimating population prevalence of injection drug use and HIV infection among injection drug users in Glasgow. American Journal of Epidemiology 1993; 138(3)170–181
- Gossop M., Griffiths P., Powis B., Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamine. British Journal of Addiction 1992; 87(11)1527–1536
- Green S., Goldberg D., Frischer M., McKeganey N. Triazolam as a substance of abuse among injecting drug users. British Journal Addiction 1992; 87(6)940–941
- Henry J. A., Jeffreys K. J., Dawling S. Toxicity and deaths from 3,4-methylenedioxymetampheta-mine ('Ecstasy'). Lancet, 1992 1992; 340: 384–397
- Morgan J. P. Mejhylenedioxymethamphetamine. Substance abuse: a comprehensive textbook 2nd edition, J. Lowinson, P. Ruiz, R. Millman, J. Langrod. Williams and Wilkins, Baltimore 1992; 331–333
- Pickering H., Donoghoe M., Green A., Foster R. Crack injection. Druglink-Journal on Drug Misuse in Britain 1993; 8(1)12
- Possilpark Group. Drug injectors in Glasgow: a community at risk. A report from a multidisciplinary group. Health Bulletin 1993; 51(6)418–429
- WHO Collaborative Study Group. An international comparative study of HIV prevalence and risk behaviour among drug injectors in thirteen cities. UN Bulletin on Narcotics 1993; XLV: 19–46